Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital twins could revolutionize mental health care for diabetes patients

NCT ID NCT07212075

Knowledge-focused Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to identify subgroups of people with diabetes who share similar patterns between their blood sugar levels and mental health. By using smartphone surveys and continuous glucose monitors, researchers will create 'digital twins'—virtual models that can predict how mental health and blood sugar change over time. The goal is to help doctors make more personalized treatment decisions for conditions like depression, anxiety, and eating disorders in people with diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,809 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study participants are enrolled from the population of people with diabetes treated at several specialised diabetes centres in South Germany. Including the Diabetes Clinic Mergentheim (DCM), Diabetes Practice Mergentheim, DiaMedicum Center Würzburg.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 to 80 years of age * Diagnosis of type 1 diabetes or type 2 diabetes or other specific type of diabetes * Diabetes duration ≥ 1 year * Sufficient German language skills * Informed consent Exclusion Criteria: * Inability to consent * Significant cognitive impairment (e.g. dementia) * Severe disorder or condition impacting the person's ability to participate in the study or likely to confound results (e.g. treated cancer, heart disease ≥ NYHA III, schizophrenia/psychotic disorder) * Terminal illness * Being bedridden

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anorexia nervosa anxiety disorder binge eating disorder Binge-Eating Disorder bipolar depression bipolar disorder bulimia nervosa Consciousness Disorders Depression depressive disorder Diabetes Complications diabetes mellitus Disordered Eating Behavior eating disorder Feeding and Eating Disorders Generalized Anxiety Disorder major depressive disorder mixed anxiety and depressive disorder panic disorder type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anorexia nervosa Anxiety disorder (panic disorder or gad) Anxiety disorder nos Anxiety symptoms Bulimia nervosa Depressed mood Depression - major depressive disorder Depression anxiety disorder Depression disorders Depression, bipolar Diabete mellitus Diabete type 1 Diabete type 2 Diabetes (DM) Diabetes complications Diabetes distress Disordered eating behaviors Eating disorder binge Eating disorder not otherwise specified Fear of hypoglycemia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Diabetes Clinic Mergentheim (DCM)

    RECRUITING

    Bad Mergentheim, Baden-Wurttemberg, 97980, Germany

  • MVZ DiaMedicum Würzburg

    COMPLETED

    Würzburg, Baden-Wurttemberg, 97072, Germany

  • MVZ Diabetespraxis Mergentheim

    COMPLETED

    Bad Mergentheim, Baden-Wurttemberg, 97980, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.